Publication | Closed Access
Anti-DLL4 Has Broad Spectrum Activity in Pancreatic Cancer Dependent on Targeting DLL4-Notch Signaling in Both Tumor and Vasculature Cells
66
Citations
38
References
2012
Year
Our findings suggest a novel therapeutic approach for pancreatic cancer treatment through antagonism of DLL4/Notch signaling.
| Year | Citations | |
|---|---|---|
Page 1
Page 1